Nalaganje...

Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?

Biomarkers, or more specifically molecular markers, can detect biochemical changes associated with disease processes and drug effects before histopathological and pathophysiological changes occur. Multiplexing technologies such as high-performance liquid chromatography/mass spectrometry (LC-MS) allo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Christians, Uwe, Klepacki, Jacek, Shokati, Touraj, Klawitter, Jost, Klawitter, Jelena
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640576/
https://ncbi.nlm.nih.gov/pubmed/23645936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.microc.2012.02.011
Oznake: Označite
Brez oznak, prvi označite!